Literature DB >> 3294024

Plasmodium falciparum: ingested anti-sporozoite antibodies affect sporogony in Anopheles stephensi mosquitoes.

J A Vaughan1, V Do Rosario, P Leland, A Adjepong, J Light, G R Woollett, M R Hollingdale, A F Azad.   

Abstract

In endemic areas, malaria-infected mosquitoes may feed upon humans who possess antibodies against malaria sporozoites. Therefore, we examined the effect that ingested anti-sporozoite antibodies have upon Plasmodium falciparum sporogony within Anopheles stephensi mosquitoes. Anti-sporozoite antibodies (IgG) traversed the midgut into the hemocoel within 3 hr following ingestion and, depending upon the titer, persisted for 6-24 hr. When fed to infected A. stephensi at 12 days postinfection (p.i.), anti-sporozoite antibodies bound to sporozoites in the hemocoel, but not to sporozoites residing in the salivary glands of the same mosquitoes. Anti-sporozoite antibodies also bound to developing oocysts when fed to infected A. stephensi at 5 days p.i. Oocysts in mosquitoes that had been fed anti-sporozoite antibodies on Day 5 p.i. produced significantly more sporozoites than did oocysts in nonimmune-fed (Day 5 p.i.) mosquitoes. In addition, the sporozoites from Day 5 immune-fed mosquitoes were significantly more infective to cultured human hepatoma cells than were sporozoites from nonimmune-fed controls. Use of hetereologous immune feedings at Day 5 p.i. did not result in an enhanced production of sporozoites, suggesting that enhancement is related to the specificity of the antibody and is not merely a nutritional effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294024     DOI: 10.1016/0014-4894(88)90088-4

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

Review 1.  Anti-sporozoite antibodies.

Authors:  M R Hollingdale
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Effect of polyclonal anti-procyclic antibodies on development of Trypanosoma brucei brucei in tsetse flies.

Authors:  B M Honigberg; R W Hampton; I Cunningham
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum development.

Authors:  Alison T Isaacs; Nijole Jasinskiene; Mikhail Tretiakov; Isabelle Thiery; Agnès Zettor; Catherine Bourgouin; Anthony A James
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

4.  Role of cysteines in Plasmodium falciparum circumsporozoite protein: interactions with heparin can rejuvenate inactive protein mutants.

Authors:  D Rathore; T F McCutchan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Effect of antibodies on the expression of Plasmodium falciparum circumsporozoite protein gene.

Authors:  B S Jesuíno; C Casimiro; V E do Rosário; H Silveira
Journal:  Int J Med Sci       Date:  2006-01-01       Impact factor: 3.738

6.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.

Authors:  H Bouharoun-Tayoun; P Attanath; A Sabchareon; T Chongsuphajaisiddhi; P Druilhe
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

Review 7.  Vector microbiota manipulation by host antibodies: the forgotten strategy to develop transmission-blocking vaccines.

Authors:  Apolline Maitre; Alejandra Wu-Chuang; Justė Aželytė; Vaidas Palinauskas; Lourdes Mateos-Hernández; Dasiel Obregon; Adnan Hodžić; Claire Valiente Moro; Agustín Estrada-Peña; Jean-Christophe Paoli; Alessandra Falchi; Alejandro Cabezas-Cruz
Journal:  Parasit Vectors       Date:  2022-01-04       Impact factor: 3.876

8.  Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes.

Authors:  Kazutoyo Miura; Erik Jongert; Bingbing Deng; Luwen Zhou; John P Lusingu; Chris J Drakeley; Michael P Fay; Carole A Long; Johan Vekemans
Journal:  Malar J       Date:  2014-07-09       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.